Skip to main content
SpringerLink
Log in

Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial

International Urogynecology Journal volume 34, pages 485–492 (2023)Cite this article

Abstract

Introduction and hypothesis

Nocturia affects health and quality of life (QoL). Current medical treatments can cause severe adverse effects, especially when treating elderly patients. Endogenous melatonin has a physiologic role in urinary bladder function, and the exogenous one may be beneficial for this condition. This article aims to evaluate the effectiveness and safety of melatonin for ameliorating nocturia in older women.

Methods

This randomized, double-blind, placebo-controlled trial was conducted at a university hospital in Thailand. Sixty women with nocturia, aged > 55 years, were prospectively recruited and were later randomly allocated to treatment (melatonin 2 mg/day, n = 30) and control (placebo, n = 30) arms for 2 weeks. Outcome measures included nocturia episodes, nocturia-related parameters, Nocturia Quality of Life Questionnaire (N-QoL) scores, and adverse events.

Results

The treatment and control groups were comparable in mean age (65.9 + 7.5 vs. 68.5 + 6.3 years). Both groups had comparable causes of nocturia with a baseline median voiding frequency of 2.3 (1.3, 6.3) and 2.3 (1.7, 5.3) episodes/night, respectively. The treatment group had significantly better outcomes than the placebo group in terms of median reduction in nocturia [-1.0 (-3.0, 0.0) vs. 0.0 (-2.3, 1.3) episodes/night; p < 0.001], increased median duration of the first uninterrupted sleep [1.0 (-0.3, 4.5) vs. 0.0 (-3.0, 2.3) h; p < 0.001], and improvement in N-QoL scoring, especially in the sleep/energy subscale (p = 0.019) and the total score (p = 0.016). Adverse events were comparable between groups.

Conclusions

Melatonin can be considered a safe and effective treatment for nocturia in elderly women.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1.
Fig. 2.

References

  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49.

    Article  Google Scholar 

  2. Tikkinen KA, Johnson TM, Tammela TL, Sintonen H, Haukka J, Huhtala H, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57:488–96.

    Article  Google Scholar 

  3. Fitzgerald MP, Litman HJ, Link CL, McKinlay JB, Survey Investigators BACH. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol. 2007;177:1385–9.

    Article  Google Scholar 

  4. Asplund R. Hip fractures, nocturia, and nocturnal polyuria in the elderly. Arch Gerontol Geriatr. 2006;43:319–26.

    Article  CAS  Google Scholar 

  5. Parsons JK, Mougey J, Lambert L, Wilt TJ, Fink HA, Garzotto M, et al. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int. 2009;104:63–8.

    Article  Google Scholar 

  6. Temml C, Ponholzer A, Gutjahr G, Berger I, Marszalek M, Madersbacher S. Nocturia is an age-independent risk factor for hip-fractures in men. Neurourol Urodyn. 2009;28:949–52.

    Article  Google Scholar 

  7. Nakagawa H, Niu K, Hozawa A, Ikeda Y, Kaiho Y, Ohmori-Matsuda K, et al. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010;184:1413–8.

    Article  Google Scholar 

  8. Lightner DJ, Krambeck AE, Jacobson DJ, McGree ME, Jacobsen SJ, Lieber MM, et al. Nocturia is associated with an increased risk of coronary heart disease and death. BJU Int. 2012;110:848–53.

    Article  Google Scholar 

  9. Asplund R. Nocturia: consequences for sleep and daytime activities and associated risks. Eur Urol Suppl. 2005;3:24–32.

    Article  Google Scholar 

  10. Udo Y, Nakao M, Honjo H, Ukimura O, Kawauchi A, Kitakoji H, et al. Analysis of nocturia with 24-h urine volume, nocturnal urine volume, nocturnal bladder capacity and length of sleep duration: concept for effective treatment modality. BJU Int. 2011;107:791–8.

    Article  Google Scholar 

  11. Udo Y, Nakao M, Honjo H, Ukimura O, Kitakoji H, Miki T. Sleep duration is an independent factor in nocturia: analysis of bladder diaries. BJU Int. 2009;104:75–9.

    Article  Google Scholar 

  12. Negoro H, Kanematsu A, Yoshimura K, Ogawa O. Chronobiology of micturition: putative role of the circadian clock. J Urol. 2013;190:843–9.

    Article  Google Scholar 

  13. Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336:186–95.

    Article  CAS  Google Scholar 

  14. Fathollahi A, Daneshgari F, Hanna-Mitchell AT. Melatonin and its role in lower urinary tract function: An article review. Curr Urol. 2015;8:113–8.

    Article  Google Scholar 

  15. Sugaya K, Nishijima S, Oda M, Owan T, Miyazato M, Ogawa Y. Biochemical and body composition analysis of nocturia in the elderly. Neurourol Urodyn. 2008;27:205–11.

    Article  CAS  Google Scholar 

  16. Cornu JN, Abrams P, Chapple CR, Dmochowski RR, Lemack GE, Michel MC, et al. A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management—a systematic review and meta-analysis. Eur Urol. 2012;62:877–90.

    Article  Google Scholar 

  17. Obayashi K, Saeki K, Kurumatani N. Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort. J Urol. 2014;191:1816–21.

    Article  CAS  Google Scholar 

  18. Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, et al. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Curr Med Res Opin. 2011;27:87–98.

    Article  CAS  Google Scholar 

  19. Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res. 2007;16:372–80.

    Article  Google Scholar 

  20. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet. 1995;346:541–4.

    Article  CAS  Google Scholar 

  21. Haimov I, Lavie P, Laudon M, Herer P, Vigder C, Zisapel N. Melatonin replacement therapy of elderly insomniacs. Sleep. 1995;18:598–603.

    Article  CAS  Google Scholar 

  22. Poeggeler B. Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine. 2005;27:201–12.

    Article  CAS  Google Scholar 

  23. Drake MJ, Mills IW, Noble JG. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol. 2004;171:1199–202.

    Article  CAS  Google Scholar 

  24. Sugaya K, Nishijima S, Miyazato M, Kadekawa K, Ogawa Y. Effects of melatonin and rilmazafone on nocturia in the elderly. J Int Med Res. 2007;35:685–91.

    Article  CAS  Google Scholar 

  25. Dijk DJ, Cajochen C, Tobler I, Borbely AA. Sleep extension in humans: sleep stages, EEG power spectra and body temperature. Sleep. 1991;14:294–306.

    Article  CAS  Google Scholar 

  26. Stanley N. The underestimated impact of nocturia on quality of life. Eur Urol Suppl. 2005;4:17–9.

    Article  Google Scholar 

  27. Nowak JZ, Zawilska JB. Melatonin and its physiological and therapeutic properties. Pharm World Sci. 1998;20:18–27.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge the women who generously agreed to participate in this study and Ms. Nerisa Thornsri, MSc of the Research Group and Research Network Division, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, for assistance with statistical analysis.

Funding

The study was funded by a grant from Siriraj Routine to Research (R2R), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Author information

Authors and Affiliations

  1. Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Pichai Leerasiri, Pimchanok Pariyaeksut, Pattaya Hengrasmee & Chutimon Asumpinwong

Authors
  1. Pichai Leerasiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pimchanok Pariyaeksut
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pattaya Hengrasmee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chutimon Asumpinwong
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

P Leerasiri: Protocol development, Data analysis, Manuscript editing

P Pariyaeksut: Data collection, Data analysis, Manuscript writing

P Hengrasmee: Manuscript editing

C Asumpinwong: Protocol development, Manuscript editing

Corresponding author

Correspondence to Chutimon Asumpinwong.

Ethics declarations

Conflicts of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leerasiri, P., Pariyaeksut, P., Hengrasmee, P. et al. Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial. Int Urogynecol J 34, 485–492 (2023). https://doi.org/10.1007/s00192-022-05232-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-022-05232-3

Keywords

search

Navigation